Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eileen Morgan

Showing results (41-50 of 49) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 49 results.
Gut|June 20, 2020
International trends in oesophageal cancer survival by histological subtype between 1995 and 2014Eileen Morgan, Isabelle Soerjomataram, Anna T Gavin, et al.
Gut|June 3, 2020
Colon and rectal cancer survival in seven high-income countries 2010-2014: variation by age and stage at diagnosis (the ICBP SURVMARK-2 project)Marzieh Araghi, Melina Arnold, Mark J Rutherford, et al.
International Journal of Cancer|December 19, 2022
Shifting incidence and survival of epithelial ovarian cancer (1995-2014): A SurvMark-2 studyCitadel J Cabasag, Melina Arnold, Mark Rutherford, et al.
Cancer Epidemiology|April 7, 2026
European expert consensus on cancer recurrence and progression data collection by population based cancer registriesSinéad T Hawkins, Helen J Mitchell, Damien Bennett, et al.
Gynecologic Oncology|February 2, 2020
Exploring variations in ovarian cancer survival by age and stage (ICBP SurvMark-2): A population-based studyCitadel J Cabasag, John Butler, Melina Arnold, et al.
Gut|November 26, 2021
International variation in oesophageal and gastric cancer survival 2012-2014: differences by histological subtype and stage at diagnosis (an ICBP SURVMARK-2 population-based study)Melina Arnold, Eileen Morgan, Aude Bardot, et al.
The New England Journal of Medicine|March 11, 2026
<i>Helicobacter pylori</i> Screen-and-Treat Programs for Gastric Cancer Prevention - IARC Working Group ReportJin Young Park, Yi-Chia Lee, Paul Moayyedi, et al.
The Lancet. Oncology|September 16, 2019
Progress in cancer survival, mortality, and incidence in seven high-income countries 1995-2014 (ICBP SURVMARK-2): a population-based studyMelina Arnold, Mark J Rutherford, Aude Bardot, et al.
The Lancet. Oncology|June 1, 2026
International disruptions to cancer diagnosis and stage at presentation during the COVID-19 pandemic in 2020: an International Cancer Benchmarking Partnership (ICBP) population-based studyEileen Morgan, Aude Bardot, Oliver Langselius, et al.
Pageof 5

Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Gut|June 20, 2020
International trends in oesophageal cancer survival by histological subtype between 1995 and 2014Eileen Morgan, Isabelle Soerjomataram, Anna T Gavin, et al.
Gut|June 3, 2020
Colon and rectal cancer survival in seven high-income countries 2010-2014: variation by age and stage at diagnosis (the ICBP SURVMARK-2 project)Marzieh Araghi, Melina Arnold, Mark J Rutherford, et al.
International Journal of Cancer|December 19, 2022
Shifting incidence and survival of epithelial ovarian cancer (1995-2014): A SurvMark-2 studyCitadel J Cabasag, Melina Arnold, Mark Rutherford, et al.
Cancer Epidemiology|April 7, 2026
European expert consensus on cancer recurrence and progression data collection by population based cancer registriesSinéad T Hawkins, Helen J Mitchell, Damien Bennett, et al.
Gynecologic Oncology|February 2, 2020
Exploring variations in ovarian cancer survival by age and stage (ICBP SurvMark-2): A population-based studyCitadel J Cabasag, John Butler, Melina Arnold, et al.
Gut|November 26, 2021
International variation in oesophageal and gastric cancer survival 2012-2014: differences by histological subtype and stage at diagnosis (an ICBP SURVMARK-2 population-based study)Melina Arnold, Eileen Morgan, Aude Bardot, et al.
The New England Journal of Medicine|March 11, 2026
<i>Helicobacter pylori</i> Screen-and-Treat Programs for Gastric Cancer Prevention - IARC Working Group ReportJin Young Park, Yi-Chia Lee, Paul Moayyedi, et al.
The Lancet. Oncology|September 16, 2019
Progress in cancer survival, mortality, and incidence in seven high-income countries 1995-2014 (ICBP SURVMARK-2): a population-based studyMelina Arnold, Mark J Rutherford, Aude Bardot, et al.
The Lancet. Oncology|June 1, 2026
International disruptions to cancer diagnosis and stage at presentation during the COVID-19 pandemic in 2020: an International Cancer Benchmarking Partnership (ICBP) population-based studyEileen Morgan, Aude Bardot, Oliver Langselius, et al.
Pageof 5